Coronado GD, Nyongesa DB, Escaron AL, Petrik AF, Thompson JH, Smith D, Davis MM, Schneider JL, Rivelli JS, Laguna T, Leo MC. Effectiveness and Cost of an Enhanced Mailed Fecal Test Outreach Colorectal Cancer Screening Program: Findings from the PROMPT Stepped-Wedge Trial. Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1608-1616. doi: 10.1158/1055-9965.EPI-23-0597. PMID: 37566431. https://aacrjournals.org/cebp/article/32/11/1608/729725/Effectiveness-and-Cost-of-an-Enhanced-Mailed-Fecal Baldwin LM, Coronado GD, West II, Schwartz MR, Meenan RT, Vollmer WM, Petrik AF, Shapiro JA, Kulkarni-Sharma YR, Green BB. Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models. Cancer. 2021 Sep 29. doi: 10.1002/cncr.33909. Epub ahead of print. PMID: 34586630. https://pubmed.ncbi.nlm.nih.gov/34586630/ Coronado GD, Rawlings AM, Petrik AF, Slaughter M, Johnson ES, Hannon PA, Cole A, Vu T, Mummadi RR. Precision Patient Navigation to Improve Rates of Follow-up Colonoscopy, An Individual Randomized Effectiveness Trial. Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. doi: 10.1158/1055-9965.EPI-20-1793. Epub ahead of print. PMID: 34583969. https://cebp.aacrjournals.org/content/early/2021/10/21/1055-9965.EPI-20-1793 Coronado GD, Kihn-Stang A, Slaughter MT, Petrik AF, Thompson JH, Rivelli JS, Jimenez R, Gibbs J, Yadav N, Mummadi RR. Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process. BMC Gastroenterol. 2021 Sep 28;21(1):356. doi: 10.1186/s12876-021-01923-1. PMID: 34583638; PMCID: PMC8477359. https://pubmed.ncbi.nlm.nih.gov/34583638/ Arredondo EM, Dumbauld J, Milla M, Madanat H, Coronado GD, Haughton J, Garcia-Bigley F, Ramers C, Nodora J, Bharti B, Lopez G, Diaz M, Marquez J, Gupta S. A Promotor-Led Pilot Study to Increase Colorectal Cancer Screening in Latinos: The Juntos Contra El Cáncer Program. Health Promot Pract. 2021 Jul;22(4):491-501. doi: 10.1177/1524839920912240. Epub 2020 Mar 22. PMID: 32202155. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364826/ Tuzzio L, Meyers CM, Dember LM, Grudzen CR, Melnick ER, Staman KL, Huang SS, Richards J, DeBar L, Vazquez MA, Green BB, Coronado GD, Jarvik JG, Braciszewski J, Ho PM, Wells BL, James K, Toto R, D'Onofrio G, Volandes A, Kuklinski MR, Catalano RF, Sterling SA, Morse EF, Curtis L, Larson EB. Accounting for quality improvement during the conduct of embedded pragmatic clinical trials within healthcare systems: NIH Collaboratory case studies. Healthc (Amst). 2021 Jun;8 Suppl 1:100432. doi: 10.1016/j.hjdsi.2020.100432. Epub 2021 Jun 23. PMID: 34175091. https://www.sciencedirect.com/science/article/pii/S2213076420300312 Coronado GD, Nielson CM, Keast EM, Petrik AF, Suls JM. The influence of multi-morbidities on colorectal cancer screening recommendations and completion. Cancer Causes Control. 2021 May;32(5):555-565. doi: 10.1007/s10552-021-01408-2. Epub 2021 Mar 9. PMID: 33687606. https://pubmed.ncbi.nlm.nih.gov/33687606/ Meenan RT, Baldwin LM, Coronado GD, Schwartz M, Coury J, Petrik AF, West II, Green BB. Costs of Two Health Insurance Plan Programs to Mail Fecal Immunochemical Tests to Medicare and Medicaid Plan Members. Popul Health Manag. 2021 Apr;24(2):255-265. doi: 10.1089/pop.2020.0041. Epub 2020 Jun 29. PMID: 32609077. https://pubmed.ncbi.nlm.nih.gov/32609077/ Coury J, Miech EJ, Styer P, Petrik AF, Coates KE, Green BB, Baldwin LM, Shapiro JA, Coronado GD. What's the "secret sauce"? How implementation variation affects the success of colorectal cancer screening outreach. Implement Sci Commun. 2021 Jan 11;2(1):5. doi: 10.1186/s43058-020-00104-7. PMID: 33431063; PMCID: PMC7802298. https://pubmed.ncbi.nlm.nih.gov/33431063/ Mojica CM, Lind B, Gu Y, Coronado GD, Davis MM. Predictors of Colorectal Cancer Screening Modality Among Newly Age-Eligible Medicaid Enrollees. Am J Prev Med. 2021 Jan;60(1):72-79. doi: 10.1016/j.amepre.2020.08.003. Epub 2020 Nov 19. PMID: 33223363; PMCID: PMC8493888. https://pubmed.ncbi.nlm.nih.gov/33223363/ Petrik AF, Keast E, Johnson ES, Smith DH, Coronado GD. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics. BMC Health Serv Res. 2020 Nov 10;20(1):1028. doi: 10.1186/s12913-020-05883-2. PMID: 33172444; PMCID: PMC7654150. https://pubmed.ncbi.nlm.nih.gov/33172444/ Petrik AF, Green B, Schneider J, Miech EJ, Coury J, Retecki S, Coronado GD. Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program in Community Health Centers: an Applied Use of Configurational Comparative Methods. J Gen Intern Med. 2020 Nov;35(Suppl 2):815-822. doi: 10.1007/s11606-020-06186-2. Epub 2020 Oct 26. PMID: 33107003; PMCID: PMC7652967. https://pubmed.ncbi.nlm.nih.gov/33107003/ Green BB, West II, Baldwin LM, Schwartz MR, Coury J, Coronado GD. Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program. J Community Health. 2020 Oct;45(5):916-921. doi: 10.1007/s10900-020-00809-9. PMID: 32219712. https://pubmed.ncbi.nlm.nih.gov/32219712/ Coronado GD, Schneider JL, Green BB, Coury JK, Schwartz MR, Kulkarni-Sharma Y, Baldwin LM.Coronado GD, et al. Health plan adaptations to a mailed outreach program for colorectal cancer screening among Medicaid and Medicare enrollees: the BeneFIT study. Implement Sci. 2020 Sep 15;15(1):77. doi: 10.1186/s13012-020-01037-4.Implement Sci. 2020. PMID: 32933525 pubmed.ncbi.nlm.nih.gov/32933525/ Coronado GD, Nyongesa DB, Petrik AF, Thompson JH, Escaron AL, Younger B, Harbison S, Leo MC. Randomized Controlled Trial of Advance Notification Phone Calls vs Text Messages Prior to Mailed Fecal Test Outreach. Clin Gastroenterol Hepatol. 2020 Jul 30:S1542-3565(20)31063-6. doi: 10.1016/j.cgh.2020.07.053. Epub ahead of print. PMID: 32739569. https://pubmed.ncbi.nlm.nih.gov/32739569/ Schneider JL, Rivelli JS, Gruss I, Petrik AF, Nielson CM, Green BB, Coronado GD. Barriers and Facilitators to Timely Colonoscopy Completion for Safety Net Clinic Patients. Am J Health Behav. 2020 Jul 1;44(4):460-472. doi: 10.5993/AJHB.44.4.8. PMID: 32553027. https://pubmed.ncbi.nlm.nih.gov/32553027/ Gupta S, Coronado GD, Argenbright K, Brenner AT, Castañeda SF, Dominitz JA, Green B, Issaka RB, Levin TR, Reuland DS, Richardson LC, Robertson DJ, Singal AG, Pignone M. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit. CA Cancer J Clin. 2020 Jul;70(4):283-298. doi: 10.3322/caac.21615. Epub 2020 Jun 25. PMID: 32583884; PMCID: PMC7523556. https://pubmed.ncbi.nlm.nih.gov/32583884/ Coronado GD. Who Is Reached With Clinic In-Reach and Outreach Strategies to Promote Colorectal Cancer Screening? Am J Public Health. 2020 Apr;110(4):437-439. doi: 10.2105/AJPH.2020.305593. PMID: 32159997; PMCID: PMC7067109. https://pubmed.ncbi.nlm.nih.gov/32159997/ Baldwin LM, Schneider JL, Schwartz MR, Rivelli JS, Green BB, Petrik AF, Coronado GD. First- Year Implementation of Mailed FIT Colorectal Cancer Screening Programs in Two Medicaid/Medicare Health Insurance Plans: Qualitative Learnings from Health Plan Quality Improvement Staff and Leaders. BMC Health Services.2020 Feb 21;20(1):132. doi: 10.1186/s12913-019-4868-5. PMID: 32085767; PMCID: PMC7035739. https://pubmed.ncbi.nlm.nih.gov/32085767/ O'Connor EA, Nielson CM, Petrik AF, Green BB, Coronado GD. Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening. Sci Rep. 2020 Feb 12;10(1):2441. doi: 10.1038/s41598-020-59032-0. PMID: 32051454; PMCID: PMC7016148. https://pubmed.ncbi.nlm.nih.gov/32051454 Davis M, Schneider JL, Gunn R, Rivelli JS, Vaughn KA, Coronado GD. A Qualitative Study of Patient Preferences for Prompts and Reminders for a Direct-Mail Fecal Testing Program. Transl Behav Med. 2020 Feb 12. https://academic.oup.com/tbm/advance-article/doi/10.1093/tbm/ibaa010/5734608 Coronado GD, Green BB, West II, Schwartz MR, Coury JK, Vollmer WM, Shapiro JA, Petrik AF, Baldwin LM. Direct-to-Member Mailed Colorectal Cancer Screening Outreach for Medicaid and Medicare Enrollees: Implementation and Effectiveness Outcomes from the BeneFIT Study. Cancer. 2020 Feb 1;126(3):540-548. doi: 10.1002/cncr.32567. Epub 2019 Oct 28. PMID: 31658375; PMCID: PMC7004121. https://pubmed.ncbi.nlm.nih.gov/31658375/ Coronado GD, Johnson ES, Leo MC, Schneider JL, Smith D, Mummadi R, Petrik AF, Thompson JH, Jimenez R. Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers. Contemp Clin Trials. 2020 Feb;89:105920. doi: 10.1016/j.cct.2019.105920. Epub 2019 Dec 24. PMID: 31881390; PMCID: PMC7254876. https://pubmed.ncbi.nlm.nih.gov/31881390/ Mojica CM, Bradley SM, Lind BK, Gu Y, Coronado GD, Davis MM. Initiation of Colorectal Cancer Screening Among Medicaid Enrollees. Am J Prev Med. 2020 Feb;58(2):224-231. doi: 10.1016/j.amepre.2019.09.015. Epub 2019 Nov 28. PMID: 31786031; PMCID: PMC7359742. https://pubmed.ncbi.nlm.nih.gov/31786031/ O'Connor EA, Vollmer WM, Petrik AF, Green BB, Coronado GD. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial. Trials. 2020 Jan 15;21(1):91. doi: 10.1186/s13063-019-4027-7. PMID: 31941527; PMCID: PMC6964086. https://pubmed.ncbi.nlm.nih.gov/31941527/ Green BB, Baldwin LM, West II, Schwartz M, Coronado GD. Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720958525. doi: 10.1177/2150132720958525. PMID: 32912056; PMCID: PMC7488888. https://pubmed.ncbi.nlm.nih.gov/32912056/ Davis MM, Gunn R, Pham R, Wiser A, Lich KH, Wheeler SB, Coronado GD. Key Collaborative Factors When Medicaid Accountable Care Organizations Work With Primary Care Clinics to Improve Colorectal Cancer Screening: Relationships, Data, and Quality Improvement Infrastructure. Prev Chronic Dis. 2019 Aug 15;16:E107. doi: 10.5888/pcd16.180395. PMID: 31418685; PMCID: PMC6716418. https://www.cdc.gov/pcd/issues/2019/18_0395.htm Nielson CM, Vollmer WM, Petrik AF, Keast EM, Green BB, Coronado GD. Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer. J Gen Intern Med. 2019 Jun;34(6):978-985. doi: 10.1007/s11606-018-4820-0. Epub 2019 Jan 25. PMID: 30684199; PMCID: PMC6544723. https://pubmed.ncbi.nlm.nih.gov/30684199/ Coronado GD, Thompson JH, Petrik AF, Nyongesa DB, Leo MC, Castillo M, Younger BM, Escaron AL, Chen A. Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study. J Am Board Fam Med. 2019 May-Jun;32(3):318-328. https://www.jabfm.org/content/jabfp/32/3/318.full.pdf Thompson JH, Davis MM, Michaels L, Rivelli JS, Younger BM, Castro M, Reich SL, Coronado GD. Developing Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program in a Latino-Based Community Health Center. J Am Board Fam Med. 2019 May-Jun;32(3):307-317. https://www.jabfm.org/content/jabfp/32/3/307.full.pdf Green BB, Coronado GD, Schwartz M, Coury J, Baldwin LM. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice. Implement Sci. 2019 May 29;14(1):53. doi: 10.1186/s13012-019-0903-5. PMID: 31142348L https://pubmed.ncbi.nlm.nih.gov/31142348/ Coury JK, Schneider JL, Green BB, Baldwin LM, Petrik AF, Rivelli JS, Schwartz MR, Coronado GD. Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates. Transl Behav Med. 2018 Nov 16. doi: 10.1093/tbm/iby094. PMID: 30445511 https://pubmed.ncbi.nlm.nih.gov/30445511/ Nielson CM, Rivelli JS, Fuoco MJ, Gawlik VR, Jimenez R, Petrik AF, Coronado GD. Effectiveness of automated and live phone reminders after mailed-FIT outreach in a pilot randomized trial. Preventive medicine reports. 2018 Oct 17. https://pubmed.ncbi.nlm.nih.gov/30364785/ Nielson CM, Petrik AF, Jacob L, Vollmer WM, Keast EM, Schneider JL, Rivelli JS, Kapka TJ, Meenan RT, Mummadi RR, Green BB, Coronado GD. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial. Cancer Medicine. 2018 Aug 13 [Epub ahead of print]. doi: 10.1002/cam4.1727 PMID: 30101513 https://pubmed.ncbi.nlm.nih.gov/30101513/ Coronado GD, Petrik AF, Vollmer WM, Taplin SH, Keast EM, Fields S, Green BB. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial. JAMA Internal Medicine. 2018 Aug 6 [epub ahead of print]. PMID: 30083752. doi:10.1001/jamainternmed.2018.3629 https://pubmed.ncbi.nlm.nih.gov/30083752/ Thompson JH, Davis MM, Leo MC, Schneider JL, Smith DH, Petrik AF, Castillo M, Younger B, Coronado GD. Participatory Research to Advance Colon Cancer Prevention (PROMPT): Study protocol for a pragmatic trial. Contemp Clin Trials.2018 Apr;67:11-15. PMCID: PMC5903679 https://linkinghub.elsevier.com/retrieve/pii/S1551-7144(17)30685-7 Petrik AF, Le T, Keast E, Rivelli J, Bigler K, Green B, Vollmer WM, Coronado G. Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers. J Community Health 2018 Feb;43(1):128-136. PMCID: PMC5767531 [Available on 2019-02-01] https://link.springer.com/article/10.1007/s10900-017-0395-7 Coronado GD, Rivelli JS, Fuoco MJ, Vollmer WM, Petrik AF, Keast E, Barker S, Topalanchik E, Jimenez R. Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches. J Gen Intern Med 2018 Jan;33(1):72-78. PMCID: PMC5756165 https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29019046/ Weinfurt KP, Hernandez AF, Coronado GD, DeBar LL, Dember LM, Green BB, Heagerty PJ, Huang SS, James KT, Jarvik JG, Larson EB, Mor V, Platt R, Rosenthal GE, Septimus EJ, Simon GE, Staman KL, Sugarman J, Vazquez M, Zatzick D, Curtis LH. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory. BMC Med Res Methodol.2017 Sep 18;17(1):144. PMCID: PMC5604499 https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-017-0420-7 Coronado GD, Schneider JL, Petrik A, Rivelli J, Taplin S, Green BB. Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders. Transl Behav Med 2017 Sep;7(3):557-566. PMCID: PMC5645273 https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28150097/ Coury J, Schneider JL, Rivelli JS, Petrik AF, Seibel E, D'Agostini B, Taplin SH, Green BB, Coronado GD. Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics. BMC Health Serv Res.2017 Jun 19;17(1):411. PMCID: PMC5477281 https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-017-2364-3 Coronado GD, Retecki S, Petrik AF, Coury J, Aguirre J, Taplin SH, Burdick T, Green BB. Mapping multi-site clinic workflows to design systems-enabled interventions. eGEMs. 2017;5(1). https://egems.academyhealth.org/articles/10.5334/egems.219/ Johnson KE, Neta G, Dember LM, Coronado GD, Suls J, Chambers DA, Rundell S, Smith DH, Liu B, Taplin S, Stoney CM. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory. Trials. 2016 Dec;17(1):32. https://www.ncbi.nlm.nih.gov/pubmed/26772801 Cook AJ, Delong E, Murray DM, Vollmer WM, Heagerty PJ. Statistical lessons learned for designing cluster randomized pragmatic clinical trials from the NIH Health Care Systems Collaboratory Biostatistics and Design Core. Clinical Trials. 2016 Oct;13(5):504-12. https://www.ncbi.nlm.nih.gov/pubmed/27179253 Larson EB, Tachibana C, Thompson E, Coronado GD, DeBar L, Dember LM, Honda S, Huang SS, Jarvik JG, Nelson C, Septimus E. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems. Healthcare. 2016 Sep 1;4(3):138-41. https://www.ncbi.nlm.nih.gov/pubmed/27637816 Oluloro A, Petrik AF, Turner A, Kapka T, Rivelli J, Carney PA, Saha S, Coronado GD. Timeliness of colonoscopy after abnormal fecal test results in a safety net practice. Journal of Community Health. 2016 Aug 1;41(4):864-70. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400284/ Petrik AF, Green BB, Vollmer WM, Le T, Bachman B, Keast E, Rivelli J, Coronado GD. The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics. Family Practice. 2016 Jul 28;33(6):639-43. https://www.ncbi.nlm.nih.gov/pubmed/27471224 Coronado GD, Retecki S, Schneider J, Taplin SH, Burdick T, Green BB. Recruiting community health centers into pragmatic research: Findings from STOP CRC. Clinical Trials. 2016 Apr;13(2):214-22. https://www.ncbi.nlm.nih.gov/pubmed/26419905 Oluloro A, Petrik AF, Coronado G, Kapka T, Rivelli JS. Timeliness of follow-up to a positive fecal immunochemical test result among community health center patients. Journal of Patient-Centered Research and Reviews. 2016;3(3):179. https://digitalrepository.aurorahealthcare.org/jpcrr/vol3/iss3/35/ Vollmer WM, Green BB, Coronado GD. Analytic Challenges Arising from the STOP CRC Trial: Pragmatic Solutions for Pragmatic Problems. EGEMS (Wash DC) 2015 Dec 9;3(1):1200. PMCID: PMC4708092 https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26793738/ Coronado GD, Petrik AF, Bartelmann SE, Coyner LA, Coury J. Health policy to promote colorectal cancer screening: Improving access and aligning federal and state incentives. Clinical researcher. 2015 Feb;29(1):50. https://www.ncbi.nlm.nih.gov/pubmed/27135047 Coronado GD, Vollmer WM, Petrik A, Aguirre J, Kapka T, DeVoe J, Puro J, Miers T, Lembach J, Turner A, Sanchez J. Strategies and opportunities to STOP colon cancer in priority populations: Pragmatic pilot study design and outcomes. BMC cancer. 2014 Dec;14(1):55. https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-55 Coronado GD, Schneider JL, Sanchez JJ, Petrik AF, Green B. Reasons for non-response to a direct-mailed FIT kit program: Lessons learned from a pragmatic colorectal-cancer screening study in a federally sponsored health center. Translational Behavioral Medicine. 2014 Sep 4;5(1):60-7. https://www.ncbi.nlm.nih.gov/pubmed/25729454 Coronado GD, Vollmer WM, Petrik A, Taplin SH, Burdick TE, Meenan RT, Green BB. Strategies and opportunities to STOP colon cancer in priority populations: Design of a cluster-randomized pragmatic trial. Contemporary Clinical Trials. 2014 Jul 1;38(2):344-9. https://www.ncbi.nlm.nih.gov/pubmed/24937017 Green B, Coronado GD, DeVoe J, Allison J. Navigating the murky waters of colorectal cancer screening and health reform. American Journal of Public Health. 2014 Jun; 104(6):982-6. PMCID: PMC4062021 https://www.ncbi.nlm.nih.gov/pubmed/24825195 Coronado GD, Sanchez J, Petrik A, Kapka T, DeVoe J, Green B. Advantages of wordless instructions on how to complete a fecal immunochemical test: Lessons from patient advisory council members of a federally qualified health center. Journal of Cancer Education. 2014 Mar 1;29(1):86-90. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946071/ Coronado GD, Burdick T, Petrik A, Kapka T, Retecki S, Green B. Using an automated data-driven, EHR-embedded program for mailing FIT kits: Lessons from the STOP CRC pilot study. Journal of General Practice (Los Angeles, Calif.). 2014 Jan 5;2. https://www.ncbi.nlm.nih.gov/pubmed/25411657